Showing: 1 - 2 of 2 RESULTS

Advocates Stand Up Against AstraZeneca to Save Drug Discount Program for Vulnerable Populations

Wilmington Protest, Wed., Oct. 14th – 12 noon – 1:00 pm ET

Dozens of concerned healthcare advocates from across the northeast region protest AstraZeneca, one of five U.S. based pharmaceutical companies that have cut back on the number of drugs they provide through the 340B federal drug discount program

Please replace the release with the following updated version due to multiple revisions.

The updated release reads:

DELAWARE PROTEST: ADVOCATES STAND UP AGAINST ASTRAZENECA TO SAVE DRUG DISCOUNT PROGRAM FOR VULNERABLE POPULATIONS

Wilmington Protest, Wed., Oct. 14th – 12 noon – 1:00 pm ET

Dozens of concerned healthcare advocates from across the northeast region protest AstraZeneca, one of five U.S. based pharmaceutical companies that have cut back on the number of drugs they provide through the 340B federal drug discount program.

Healthcare advocates from across the northeast region will protest the recent actions of AstraZeneca, in cutting back the number of critical life-saving drugs provided at discounted rates to non-profit healthcare providers, through the federal 340B drug discount program.

WHAT:

Protest against AstraZeneca

 

 

WHERE:

AstraZeneca’s Corporate Office

 

1800 Concord Pike, Wilmington, DE 19803

 

NOTE: The protest will take place at the intersection of Powder Mill Road & Route 22

 

 

WHEN:

Tomorrow, Wednesday, October 14, 2020

 

12noon – 1pm (EDT)

 

 

WHO:

Healthcare advocates from across the Northeast Region

The federal 340B Drug Discount Program is a lifeline that allows safety net providers, including HIV/AIDS clinics receiving funding through the Ryan White program, to obtain prescription drugs at below-retail prices. The program was established with bipartisan support as part of the Veterans Health Care Act of 1992. With 340B savings, Ryan White clinics are able to stretch their grant funds, offer a wider range of services, and improve the quality of care persons living with HIV/AIDS receive. The program also benefits qualified 340B covered entities such as non-profit rural health facilities, community clinics and children’s hospitals that serve vulnerable populations.

Tomorrow’s protest, led by healthcare advocates from AIDS Healthcare Foundation (AHF), follows a lawsuit filed by Ryan White Clinics for 340B Access (RWC-340B) against the U.S. Department of Health and Human Services (HHS), in U.S. District Court for the District of Columbia, to require the HHS secretary to take action against AstraZeneca and three other pharmaceutical companies, including Eli Lilly, Novartis and the U.S. division of Sanofi-Aventis which are illegally withholding drugs they are required to sell through the 340B program. With tomorrow’s protest, AHF is demanding that these greedy pharmaceutical companies stop their bullying tactics that will have a devastating impact on the healthcare and well-being of our most vulnerable populations (see LITIGATION PRESS RELEASE). RWC340B also recently released a study on the potential adverse impact of policies reducing resources to Ryan White clinics, see WHITE PAPER, PRESS RELEASE, and FACT SHEET.

“AstraZeneca has launched an assault on a federal drug discount program essential to the safety net of our nation’s health care,” stated John Hassell, AHF’s national director of advocacy. “They are messing with the numerous health care centers

High-intensity exercise has no effect on mortality rate in older populations, study suggests

High-intensity exercise does not appear to add to risk of mortality among older adults, a new study has found.

INTERMITTENT FASTING MAY CAUSE MUSCLE LOSS MORE THAN WEIGHT LOSS, STUDY SAYS

The research, which was published in The BMJ medical journal on Wednesday, found that HIIT (high-intensity interval training) and MICT (moderate-intensity continuous training) for those aged 70-77 showed no increase in the risk of mortality compared to recommended daily activity.

FITNESS INFLUENCER SHOWS HOW ‘BEFORE AND AFTER’ PHOTOS ARE MANIPULATED

”This study suggests that combined MICT and HIIT has no effect on all-cause mortality compared with recommended physical activity levels,” the study authors from the Norwegian University of Science and Technology in Norway, Newsgram reported.

Participants were splits into a control group, HIIT group and MICT group.

Participants were splits into a control group, HIIT group and MICT group.
(iStock)

GYM-GOER IN TENNESSEE OPENS UP AFTER EMPLOYEE THREATENED TO KICK HER OUT FOR WEARING A SPORTS BRA

The research followed a group of 1,567 men and women – 790 women and 777 men – in Norway over the course of five years.

The participants were put into a control group of 780 that followed Norwegian guidelines for physical activity, which state 30 minutes of moderate physical activity five times a week, MICT group of 387 and a HIIT group of 400. The HIIT group did two weekly high-intensity workout sessions, while the MICT did two moderate-intensity 50 minute workout sessions a week.

At the end of the five year study, the mortality rate for the combined HIIT and MICT group was 4.5%, nearly half the expected outcome of 10%, which is based on the 2% yearly mortality rate for people aged 70-75 according to Norway’s statistics. This supports the researchers expectations from “observational studies [that] have shown that older adults who are physically active have a higher health related quality of life than those who are less physically active,” the report read.

The mortality rate for the two groups compared to the control group, which was 4.7%, suggested no large difference in mortality rate among the exercise styles.

CLICK HERE TO SIGN UP FOR OUR LIFESTYLE NEWSLETTER

Though researchers noted before the study 87.5% of participants reported “overall good health,” thus suggesting a possible selection bias that could have influenced results.

Source Article